Reliable generation and use of MHC class II:γ2aFc multimers for the identification of antigen-specific CD4+ T cells

Journal of Immunological Methods

Volumn 271, Issue 1-2, 2002, Pages 137-151

  Arnold, Paula Y ^a   Vignali, Kate M ^a   Miller, Timothy B ^b   La Gruta, Nicole L ^a   Cauley, Linda S ^b   Haynes, Laura ^b   Scott Adams, P ^b   Swain, Susan L ^b   Woodland, David L ^b   Vignali, Dario A A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b TRUDEAU INSTITUTE   (United States)

Author keywords

Flow cytometry; Immunoglubulin fusion proteins; MHC class II; Peptide binding assay; T cells; Tetramers

Indexed keywords

CD4 ANTIGEN; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; LEUCINE ZIPPER PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; POLYMER; REAGENT;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DIMERIZATION; DROSOPHILA MELANOGASTER; EFFECTOR CELL; FLOW CYTOMETRY; IMMUNOCYTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN SYNTHESIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; DROSOPHILA MELANOGASTER; EPITOPES, T-LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULIN FRAGMENTS; INFLUENZA A VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PLASMIDS; RECOMBINANT PROTEINS; SENDAI VIRUS; SPECIFIC PATHOGEN-FREE ORGANISMS; TUMOR CELLS, CULTURED;

DROSOPHILA MELANOGASTER; MELANOGASTER; MURINAE;

EID: 0037146779     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(02)00343-5     Document Type: Article

References (32)

1. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94.
2. Appel H., Gauthier L., Pyrdol J., Wucherpfennig K.W. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells. Journal of Biological Chemistry. 275:2000;312.
3. Burrows G.G., Bebo B.F. Jr., Adlard K.L., Vandenbark A.A., Offner H. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis. Journal of Immunology. 161:1998;5987.
4. + T cells by HLA-DR1 oligomers is dependent on the T cell activation state. Journal of Immunology. 166:2001;741.
5. Carson R.T., Vignali K.M., Woodland D.L., Vignali D.A.A. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity. 7:1997;387.
6. Crawford F., Kozono H., White J., Marrack P., Kappler J. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8:1998;675.
7. Daly K., Nguyen P., Woodland D.L., Blackman M.A. Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire. Journal of Virology. 69:1995;7416.
8. Fahmy T.M., Bieler J.G., Edidin M., Schneck J.P. Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen. Immunity. 14:2001;135.
9. + T cells in primary and secondary influenza pneumonia. Immunity. 8:1998;683.
10. Gentz R., Rauscher F.J. III, Abate C., Curran T. Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science. 243:1989;1695.
11. Gutgemann I., Fahrer A.M., Altman J.D., Davis M.M., Chien Y.H. Induction of rapid T cell activation and tolerance by systemic presentation of an orally administered antigen. Immunity. 8:1998;667.
12. Hamad A.R., O'Herrin S.M., Lebowitz M.S., Srikrishnan A., Bieler J., Schneck J., Pardoll D. Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor. Journal of Experimental Medicine. 188:1998;1633.
13. + T cells. Journal of Experimental Medicine. 179:1994;1539.
14. + T cells. Journal of Immunology. 149:1992;1319.
15. + T cells in transgenic mice expressing a class II MHC-restricted antigen receptor. Nature. 341:1989;746.
16. Kotzin B.L., Falta M.T., Crawford F., Rosloniec E.F., Bill J., Marrack P., Kappler J. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 97:2000;291.
17. Kozono H., White J., Clements J., Marrack P., Kappler J. Production of soluble MHC class II proteins with covalently bound single peptides. Nature. 369:1994;151.
18. Liu H.Y., Vignali D.A. Differential CD3ζ phosphorylation is not required for the induction of T cell antagonism by altered peptide ligands. Journal of Immunology. 163:1999;599.
19. Lund J., Winter G., Jones P.T., Pound J.D., Tanaka T., Walker M.R., Artymiuk P.J., Arata Y., Burton D.R., Jefferis R. Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG. Journal of Immunology. 147:1991;2657.
20. + T cells in resistant mice upon infection with Leishmania major. Immunity. 13:2001;771.
21. McHeyzer-Williams M.G., Altman J.D., Davis M.M. Enumeration and characterization of memory cells in the TH compartment. Immunological Reviews. 150:1996;5.
22. Novak E.J., Liu A.W., Nepom G.T., Kwok W.W. MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen. Journal of Clinical Investigation. 104:1999;R63-R67.
23. Persons D.A., Allay J.A., Allay E.R., Smeyne R.J., Ashmun R.A., Sorrentino B.P., Nienhuis A.W. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood. 90:1997;1777.
24. Persons D.A., Allay J.A., Riberdy J.M., Wersto R.P., Donahue R.E., Sorrentino B.P., Nienhuis A.W. Use of the green fluorescent protein as a marker to identify and track genetically modified hematopoietic cells. Nature Medicine. 4:1998;1201.
25. Persons D.A., Mehaffey M.G., Kaleko M., Nienhuis A.W., Vanin E.F. An improved method for generating retroviral producer clones for vectors lacking a selectable marker gene. Blood Cells, Molecules, and Diseases. 24:1998;167.
26. Peterson D.A., DiPaolo R.J., Kanagawa O., Unanue E.R. Negative selection of immature thymocytes by a few peptide-MHC complexes: differential sensitivity of immature and mature T cells. Journal of Immunology. 162:1999;3117.
27. Reay P.A., Wettstein D.A., Davis M.M. pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule. EMBO Journal. 11:1992;2829.
28. Van Parijs L., Peterson D.A., Abbas A.K. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity. 8:1998;265.
29. Vignali D.A.A., Vignali K.M. Profound enhancement of T cell activation mediated by the interaction between the T cell receptor and the D3 domain of CD4. Journal of Immunology. 162:1999;1431.
30. Wines B.D., Powell M.S., Parren P.W., Barnes N., Hogarth P.M. The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A. Journal of Immunology. 164:2000;5313.
31. Yang Y., Vanin E.F., Whitt M.A., Fornerod M., Zwart R., Schneiderman R.D., Grosveld G., Nienhuis A.W. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Human Gene Therapy. 6:1995;1203.
32. + T cell memory. Journal of Immunology. 164(6):2000 Mar. 15;3274-3282.